Environmental endocrine disruptors (EEDs) that affect androgen or estrogen activity may disrupt gene regulation during phallus development to cause hypospadias or a masculinized clitoris. We treated developing male tammar wallabies with estrogen and females with androgen from day 20-40 postpartum (pp) during the androgen imprinting window of sensitivity. Estrogen inhibited phallus elongation but had no effect on urethral closure and did not significantly depress testicular androgen synthesis. Androgen treatment in females did not promote phallus elongation but initiated urethral closure. Phalluses were collected for transcriptome sequencing at day 50 pp when they first become sexually dimorphic to examine changes in two signaling pathways, sonic hedgehog (SHH) and wingless-type MMTV integration site family (WNT)/β-catenin. SHH mRNA and β-catenin were predominantly expressed in the urethral epithelium in the tammar phallus, as in eutherian mammals. Estrogen treatment and castration of males induced an upregulation of SHH, while androgen treatment downregulated SHH. These effects appear to be direct since we detected putative estrogen receptor α (ERα) and androgen receptor (AR) binding sites near SHH. WNT5A, like SHH, was downregulated by androgen, while WNT4 was upregulated in female phalluses after androgen treatment. After estrogen treatment, WIF1 and WNT7A were both downregulated in male phalluses. After castration, WNT9A was upregulated. These results suggest that SHH and WNT pathways are regulated by both estrogen and androgen to direct the proliferation and elongation of the phallus during differentiation. Their response to exogenous hormones makes these genes potential targets of EEDs in the etiology of abnormal phallus development including hypospadias.
Introduction
Phallus development is an androgen-dependent process [1] [2] [3] [4] [5] [6] , controlled by multiple molecular signaling pathways, including the sonic hedgehog (SHH) and WNT/β-catenin pathways. Loss of Shh [7, 8] or β-catenin [9] in the developing phallus prevents urethral closure, resulting in hypospadias. Hypospadias is an increasingly common developmental defect that affects approximately 1/125 live male births in developed countries [10] . The increasing frequency of 2% each year cannot be explained by mutations and therefore must have an environmental origin [11] [12] [13] . Environmental endocrine disruptors (EEDs), compounds that interfere with or induce androgen or estrogen activity, such as insecticides, herbicides, and many plastics, are likely responsible for the increasing incidence of hypospadias [14] [15] [16] [17] [18] [19] [20] [21] . Exposure to the androgen receptor (AR) inhibitor flutamide feminizes the phallus and causes hypospadias in mice [19, 20, 22] , rats [21, 23] , and the tammar wallaby [24] . In females, masculinization of the female phallus and an enlarged clitoris can be induced by androgenic EEDs [2, 5, [25] [26] [27] . In some elegant experiments, Zheng et al. established the importance of the balance between AR and estrogen receptor α (ERα) activity to maintain normal penile development [20] . Interfering with this balance either by treatment with AR (flutamide) and ERα (fulvestrant) inhibitors or conditional knockout of Ihh induces micropenis via the hedgehog and WNT signaling pathways [20] . To understand the ontology of external genital development and how EEDs potentially affect phallus development, we examined the effects of exogenous androgen and estrogen on two interacting signaling pathways essential for penis development, namely the SHH and the WNT/β-catenin pathways.
In mice, Shh is a dual regulatory morphogen controlling outgrowth and patterning of the genital tubercle (GT) and urethral formation [28] [29] [30] [31] . It is expressed in the cloacal membrane of the early embryo before GT protrusion and appears essential for the regulation of epithelial-mesenchymal interactions between the urethral plate epithelium and the adjacent mesenchyme [28] [29] [30] [31] . SHH and its effector GLI2 influence mesenchymal differentiation adjacent to the urethral epithelium and facilitate androgen responsiveness [29, 32, 33] . Both are important in maintaining cell proliferation and survival [29, 31] . GLI family proteins are involved in SHH signaling transduction [33, 34] , and GLI Family Zinc Finger 2 (GLI2) transcription factor mediates hedgehog signaling and regulates GT mesenchymal differentiation. The transcription of Gli genes is regulated by two membrane receptors, Patched 1(PTCH1) [35, 36] and Smoothened (SMO) [35, 37] . In the absence of hedgehog signaling, PTCH1 inhibits SMO, which further inactivates GLI transcription factors [38] . Patched 2 (PTCH2), the product Ptch2, a paralogue of Ptch1, also acts to suppress SHH signaling during early embryonic development [39] .
Several WNT family genes, including Wnt3, Wnt4, Wnt5a, Wnt7a, and Wnt9b, are expressed in the mesenchyme and ectoderm of the GT [8, 9, 30, 40] . In mice, β-catenin is mainly located in the endodermal epithelium of the undifferentiated phallus [41] . Mesenchymal β-catenin and ectodermal β-catenin promote cell proliferation and maintain cellular integrity during GT outgrowth [42] . Conditional knockout of β-catenin causes severe hypospadias [9] . WNT inhibitory factor 1 (WIF1), a secreted protein, regulates endodermal cell apoptosis during cloaca septation by inhibiting the WNT/β-catenin signaling pathway [43] [44] [45] . WIF1 inhibits the WNT/β-catenin signaling pathway by directly binding to WNT molecules and subsequently causes degradation of β-catenin [43] . Dysregulation of Wif1 causes failure of cloacal septation and induces a hypospadiaslike phenotype which is similar to that seen in Shh-null mutants [45] , indicating that Wif1 is also involved in phallus development.
During GT outgrowth in mice, SHH, upstream of WNT/β-catenin signaling, regulates cell proliferation by controlling WNT/β-catenin activity [41] . The phallus outgrowth and the level of WNT/β-catenin signaling activity are SHH signal dosage dependent [41] . Loss of SHH signaling arrests proliferation or induces apoptosis [31] , decreases Wnt gene expression and reduces WNT/β-catenin signaling activity [41] . In addition, the presence of androgen maintains WNT/β-catenin signaling activity. β-catenin itself may interact with AR to enhance AR-mediated activation of gene targets, thereby masculinizing the male phallus [9] .
Although the role of SHH and WNT signaling in phallus development are well studied in mice, usually by gene knockouts [30, 46] , hormonal regulation of these genes in the phallus during early fetal development is still unclear. The inaccessibility of mouse fetuses in utero hampers experimental hormonal manipulation. In marsupials, sexual differentiation of the phallus occurs postnatally, so these mammals provide a unique opportunity for the study of hormonal regulation of gene expression. It is possible to administer steroids directly to the young during the long phase of postnatal phallus differentiation and urethral closure without the complicating effects of maternal physiology and placental transfer. This is the first study to administer steroid hormones directly to developing young with indifferent phalluses to investigate hormonal responsiveness of key genes in the phallus.
Phallus development in tammar wallabies is similar to that in other mammals but sexual differentiation occurs after birth. The initiation of GT outgrowth is evident 2 days before birth [47] , but subsequent differentiation occurs postnatally. From birth to day 50 postpartum (pp), there is no obvious morphological difference between the male and female phallus [27] . After day 50 pp, the distance between the urethral meatus and the anus in males becomes greater than that in females [27, 47, 48] . By day 60 pp, the male GT has elongated and becomes longer than that in females [5] . In addition, the urethral groove in the penis begins to close along the ventral midline so the urethral opening gradually moves from proximal to distal [27] . By day 150 pp, urethral closure is complete, with the urethral meatus in the glans penis. In the female phallus, the urethral groove does not fuse [5, 27] . There is also a prominent tubular diverticulum in males, a conserved structure confluents with the urethra that is also found in the goat [49] and human penis [50] , but in tammar females it remains as a solid cord [5, 27] .
As in mice and humans, development of the tammar male phallus is androgen-dependent [51] . However, the earliest sexually dimorphic differences occur at a time when circulating androgen levels are similar in males and females [5, 27] , suggesting that hormonalresponsive pathways are differentially activated before sexual differentiation of the phallus. This hormone-sensitive window (androgen imprinting window) [5] was the first of several now described in mammals and occurs between day 25 and 30 pp [52] . Hormonal exposure in this early phase of development is critical for initiating the later outgrowth of the phallus and initiating urethral closure [5] . Altering hormone levels during this window of sensitivity contributes to hypospadias or sex-reversed phallus development at later stages [5, 51] .
In tammars, the testosterone concentration increases in testes from day 2 pp to day 40 pp [53] . After day 40 pp, the testosterone concentration of the testes drops rapidly to day 50 pp [53, 54] . However, the main secreted androgen in developing tammars is not testosterone but 5α-androstane-3α,17β-diol (adiol), which is reversibly converted to dihydrotestosterone (DHT) by 3α-hydroxysteroid dehydrogenase in the target organs by an alternate steroid synthesis pathway [55] . There is a strong evidence that adiol is responsible for virilization of the tammar urogenital tract produced by the alternate pathway [55, 56] , and adiol levels are sexually dimorphic at the time of virilization of the urogenital sinus [56] .
SHH mRNA has a similar localization in the early prenatal tammar phallus as that seen in mice [29, 30] . It is detected in the urethral plate epithelium 1 day before birth [52] . SHH expression remains low during the androgen-dependent window of sensitivity (day 25-30 pp) we defined when androgen imprinting occurs, but is upregulated around day 50 pp when testicular androgens have decreased and sexual differentiation of the phallus starts [52] . In male young castrated at day 29 pp, SHH is upregulated transiently at day 50 pp and, similarly, it is downregulated in female phalluses after treatment with the potent androgen adiol [52] .
Marsupials have been separated from eutherian mammals for over 160 million years [57] . The mechanisms that are conserved between marsupials and eutherians are likely core components of phallus development. In this study, we investigated the effects of hormonal manipulation on the morphology and gene expression in the developing phallus of tammar young. We treated females with adiol (the primary circulating androgen when urethral closure is occurring) and males with estrogen or castration during the androgen imprinting window. We performed RNA-Seq and in situ hybridization to determine the transcriptional and mRNA localization changes of key genes in the SHH and WNT/β-catenin signaling pathways.
Materials and methods

Animals
Tammar wallabies (Macropus eugenii) of Kangaroo Island (South Australia) origin were held kept in our breeding colony in Melbourne. Females were monitored daily from 25 to 30 days after removal of pouch young to check for newborn young [58] . The sex of the young was identified by the presence of scrotal or mammary primordia [59] . For young of unknown day of birth, age was estimated from measurements of head length and weight from published growth curves [60] . All tissues were collected under appropriate permits, and experiments approved by the University of Melbourne Animal Experimentation Ethics Committees in accordance with the National Health and Medical Research Council of Australia (2013 and 2014) guidelines.
Phalluses were measured using calipers at day 150 pp. Phalluses were everted by gently pressing the side of the GT and were measured from the tip of the glans to the bottom of the shaft as previously described [5] . Pouch young treated with steroids were killed at day 50 pp or day 150 pp for morphological study and gene expression analysis. Phalluses were either snap-frozen or stored in -80
• C for later RNA-Seq (n = 5), or fixed in 4% paraformaldehyde, embedded in paraffin, and cut into 5-μm sections for histological analysis (n = 3) and cut into 7-μm sections for section in situ hybridization (n = 3). Phallus samples for morphological analysis (n = 3) were collected from additional day 20 pp and day 90 pp males and females. The male pouch young (n = 5) were castrated at day 25 pp as previously described [61] [62] [63] or orally treated with estrogen every day between day 20 and day 40 pp (n = 5) as previously described [51, 64] . Female pouch young (n = 5) were injected with androstanediol (adiol) from day 20 pp to day 40 pp as previously described [52] . Phalluses were collected at day 50 pp (n = 5) for RNA-Seq (see below). A second treated group (n = 5) was left until day 150 pp before sampling tissues. Testes from estrogen-treated male pouch young (n = 5) and normal male pouch young (n = 5) were collected to measure the testicular testosterone concentration and to compare morphology.
RNA extraction and cDNA preparation
Before extracting RNA from samples, the frozen samples were homogenized in TRIzol reagent (Cat# 15596026, ThermoFisher Scientific). RNA was extracted from developing phalluses with the RNeasy Mini kit (Cat# 74804, QIAgen) following on the manufacturer's recommendations. The RNA was calculated with Qubit 2.0 fluorometer (ThermoFisher Scientific). All RNA samples were treated with DNA-free enzyme (Cat#1906, Ambion) to prevent genomic DNA contamination. Total RNA (200 ng) was used for cDNA template synthesis by using transcription high fidelity cDNA Synthesis kit (Cat# 05081963001, Invitrogen).
Section mRNA in situ hybridization
Paraffin-embedded phalluses were sectioned at 7 μm. The probe primers were designed with the online program Primer 3 (http://primer3.ut.ee/) (SHH: forward:
5 -AGCAGTTTATCCCCAACGTG-3 , reverse: 5 -GCGGTTGATGAGAATGGTG-3 ). Digoxin was used to label probes (Cat# 11277073910, Roche). T7 or SP6 promoters were used to in vitro transcribe the sense or antisense probes with T7/SP6 polymerase (Cat# P1460, Promega). Prehybridization was processed for 2 h at 42
• C, and hybridization for [16] [17] [18] h at 42
• C. The slides were then washed and incubated with anti-digoxigenin-AP (1:300 dilution) (Cat# 11093274910, Roche) for 16-18 h at 4
• C. NBT/BCIP (1:50 dilution) was used for color development (Cat# 11681451001, Roche). Nuclear Fast Red solution was used for count-staining (Cat# N3020, Sigma Aldrich). Negative controls (sense probe) were made for every age and sex for in situ hybridization (SupplementaryFigure 1 and data not shown).
Immunofluorescence
The paraffin-embedded phalluses were sectioned at 5 μm. The sections were deparaffinized with histolene, and rehydrated through a series of ethanol dilutions from 100% to water. Antigen retrieval was performed by heating in 30% power of a microwave (1000 W) for 20 min. The primary antibody, β-catenin antibody, (rabbit, Cat# sc-7199, Santa Cruz, Australia, 1:100 dilution) or SHH antibody (rabbit, Cat# ab19897, Abcam, USA, 1:100 dilution) (Supplementary Table S1 ) was added on the section, and incubated at 4
• C overnight. The secondary antibody (Alexa Fluor 555 donkey anti-rabbit, 1:1000, 2mg/mL, Cat# A-31572, Invitrogen) was performed at room temperature for 1 h. DAPI (1:10,000 5 mg/ml, Cat# D3571, Invitrogen) was used as a nuclear counterstain. Fluorescent Mounting Medium (Cat# S302380, Dako) was used for mounting. The edges of the coverslips were sealed with nail polish and stored at 4
• C in the dark. Negative controls, which incubated with IgG Rabbit
Immunoglobulin Fraction (Cat# X0936, Dako), were made for every age and sex for antibody sections (Supplementary Figures S1 and S2 ).
Steroid extraction and competitive ELISA
The testes were homogenized in 400 μL acetonitrile (Cat# 270717, Sigma). The supernatant was separated with centrifuging at 10 160× g for 10 min at 4
• C. Eight hundred microliter of hexane (Cat# 24577.323, BDH Prolabo) was added in the supernatant and mixed vigorously for 5 min. The upper layer was transferred into another clean tube, and the liquid was evaporated with a SpeedVac concentrator (Quantum Scientific, Biostrategy, USA). The dried sample was dissolved with 100 μL of ethanol followed by 900 μL of 1% bovine serum albumin in phosphate-buffered saline (PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 ). A testosterone ISWE Mini-Kit (Cat# ISWE001, Arbor Assays, USA) was used to measure the testosterone concentration in normal day 50 pp testes (n = 5) and estrogen-treated day 50 pp testes (n = 5) in the tammar. Nunc MaxiSorp flat-bottom 96 well plates (Cat# 44-2404-21 Thermo-Fisher) were coated with goat anti-rabbit IgG antibody (2 μg/mL, Cat# E0432, Dako) at 4
• C for overnight. One hundred microliter of 1:100 ISWE testosterone antibody was added into each well and incubated at room temperature in the dark for overnight. The plates were blocked for 30 min at room temperature with 3% BSA in PBS with 0.05% Tween. After blocking, 50 μL of diluted samples, controls and standards were added to the plates, and 100 μL of ISWE HRP-conjugated testosterone was added in the plates. The plates were incubated at room temperature for 3 h in the dark. Color reaction was carried out with adding 100 μL of TMB solution (Cat# 002023, Invitrogen) for 30 min. One hundred microliter of 1N HCL was added to stop the reaction. The measurement was conducted with a microplate reader at 620 nm weave length. All steps were conducted on a shaker except for the plate coating and blocking. Plates were washed three times with PBST after every step except for the blocking. We used five-parameter logistic curve fitting to do the calculation, the spike recovery is 95.90% ± 2.43%, the goodness of fit >0.999. The data are expressed as ng testosterone per mg of testis.
Promoter prediction
AR-and ERα-binding sites in the promoter region of SHH in the mouse were found using the Gene Transcription Regulation Database (GTRD) [65] . The upstream and downstream sequences of SHH in the tammar were extracted from the tammar wallaby genome 3.0 (Pask, A.J. Renfree, M.B. Personal communication). We used the mouse androgen receptor element (ARE) and estrogen receptor element (ERE) to predict AR-and ERα-binding sites in the tammar SHH nearby regions. The prediction was conducted by JASPAR online Scan program [66] .
RNA-Seq assembly and analysis
RNA samples were further tested using TapeStation (Agilent). Appropriate amounts of RNA were subjected to multiplex indexed-RNA-Seq analyses using TruSeq kit (Illumina) and HiSeq2500 analyzer (Illumina). Roughly 10-14 × 10 6 reads (100 bp) were obtained from each sample after Q.V. > 30 filtering. Average quality score was ∼39. The RNA-Seq data were assembled with Trimmomatic [67] and Cufflinks-Cuffdiff [68] pipeline and analyzed with CummeRbund R package [69] . The average of mapping rate from all samples was above 80%, and the quality was good for differential expression analysis. The tammar wallaby genome 3.0 (Pask, A.J. Renfree, M.B. Personal communication) was used as a guide for transcriptome assembly. The annotation was obtained by blasting against the UNIPROT protein database [70] . Differentially expressed genes were extracted with CummeRbund R package and basic R scripts [71] . Genes of interest in each signaling pathway were selected by comparing our differentially expressed genes from RNA-Seq with genes from GeneCards database (http://www.genecards.org/). FPKM (fragments per kilobase of exon model per million reads mapped) is a normalized estimation of gene expression based on RNA-Seq data. FPKM are calculated from the number of reads that mapped to each particular gene sequence taking into account the gene length and the sequencing depth [72] .
Statistics
Data were analyzed using R version 3.12 [71] and nplr package (for ELISA) [73] . Phallus lengths (n = 3-5 replicates) between different treatment groups and control groups were compared using Student t-test. Five-parameter logistic regressions were used to fitting a standard curve for ELISA results. Student t-test was used to compare the significance of differences of testicular testosterone concentration between groups and to calculate the significance of differences of gene expression between groups. All error bars represent for standard error of the mean (SEM)
Results
Androgen-and estrogen-regulated urethral closure and phallus growth in the tammar
In males at day 150 pp, the urethra is closed, and the diverticulum has a lumen, but in females at day 150 pp the urethra remains open and the diverticulum is present as a solid cord of epithelial cells (Figure 1 ). Male phalluses were significantly longer than in females ( Figure 1 ). Estrogen treatment during the androgen imprinting window (day 20-40 pp) significantly inhibited phallus elongation in males (Figure 1 ) but did not inhibit urethral closure (Figure 1) . Conversely, short-term exposure to androgens during the androgen imprinting window in females did not cause phallus elongation (Figure 1) , but did induce urethral closure (Figure 1 ). We also compared the testicular testosterone concentration and testicular morphology between normal day 50 pp testes and estrogen-treated day 50 pp testes. There was variability in concentrations as expected [74, 75] , but there were no significant difference in testicular testosterone concentration nor any morphological differences between those two groups at day 50pp, 10 days after estrogen treatment ceased ( Figure 2 ).
β-catenin gene expression was androgen-independent and localized in the urethral epithelium
There was no sexually dimorphic mRNA expression of β-catenin between normal male phalluses and normal female phalluses at day 50 pp (Figure 3 ). The expression of β-catenin was not affected by adiol treatment, estrogen treatment, or castration. The protein localization of β-catenin was predominantly found in the cellular membranes, but not in the nucleus of the external epithelium and urethral epithelium from day 20 pp to day 90 pp in both sexes (Supplementary Figure S3 ). β-catenin was detected weakly in corpora cavernosa (Supplementary Figure S3) .
WIF1 and WNT genes were hormonally responsive during phallus differentiation
In contrast to β-catenin, other WNT pathway genes were affected by androgen or estrogen treatment. WIF1 expression was significantly higher in males than in females at day 50 pp (Figure 3 ). Estrogen treatment decreased WIF1 expression to a similar level to that observed in female phalluses (Figure 3 ). Adiol treatment did not affect WIF1 expression (Figure 3 ). The expression of WNT4 and WNT Family Member 11 (WNT11) was significantly higher in normal males than that in normal females at day 50 pp (Figure 3) . Interestingly, WNT11 was not affected by adiol treatment, estrogen treatments, or castration. Adiol treatment in females upregulated WNT4 expression to a similar level to that observed in male phalluses ( Figure 3 ). The expression of WNT Family Member 5A (WNT5A) was significantly higher in normal females than that in males ( Figure 3 ). Adiol treatment in females decreased WNT5A expression to a similar level to that seen in male phalluses (Figure 3 ). After castration, WNT5A expression increased to a similar level seen in female phalluses (Figure 3 ). The expression of WNT Family Member 7A (WNT7A) and WNT Family Member 9A (WNT9A) did not differ between sexes (Figure 3) . However, the expression of WNT7A was downregulated when males were treated with estrogen, whereas WNT9A was upregulated after castration ( Figure 3 ).
Conserved distribution of SHH in the urethral epithelium in the tammar
SHH protein was detected primarily in the urethral epithelium in male and female fetal phalluses at day 25 pp (Figure 4 ). Both SHH mRNA and protein were also found in the skin and urethral epithelium in day 20 pp male and female phalluses (Figure 4) . SHH mRNA distribution in day 90 pp phalluses is similar to that of day 20 pp phalluses ( Figure 4) . Interestingly, SHH mRNA was also found in the mesenchymal cells surrounding the diverticulum and the corpora cavernosa and persisted in the diverticulum and urethral epithelium after urethral closure in the male at day 90 and in the open urethra in the female (Figure 4 ).
SHH and PTCH2 were hormonally responsive during phallus differentiation
The expression patterns of SHH and PTCH2 were altered at day 50 pp, when phalluses began to be sexually dimorphic, although other downstream members of this pathway changed little (see below). SHH mRNA was significantly higher in female phalluses than in males. Estrogen treatment of males and castration upregulated SHH expression in male phalluses, while adiol treatment downregulated SHH expression in female phalluses ( Figure 5 ). The AR and ERα protein sequences are highly conserved between mice and the tammar (Supplementary Figure S4) . The DNA-binding domain of AR and ERα between two species both shared 100% identity in amino acid sequences (Supplementary Figure S4) . Therefore, it is possible to predict the AR-and ERα-binding sites in the promoter of SHH in the tammar with mice ARE and ERE. In mice, multiple AR-and ERα-binding sites were identified in the promoter of Shh and, similarly, multiple predicted AR-and ERα-binding sites were found in the promoter of SHH in the tammar ( Figure 5 ).
PTCH2 expression was significantly higher in day 50 pp female phalluses and phalluses of castrate males when compared to day 50 pp male phalluses. However, there were no dramatic changes in the expression of the downstream target genes (GLI1, GLI2, GLI3, PTCH1, and SMO) after steroid hormone treatments ( Figure 5 ).
Discussion
This study investigated the hormonal regulation of SHH and WNT/β-catenin signaling pathways during tammar phallus development. After treatment of females with androgen or males with estrogen during the androgen imprinting window, or the removal of androgens from males through castration, there was stunted phallus growth and failure of urethral closure resulting in hypospadias. This was accompanied by significant changes in SHH and WNT gene expression. The up-and downregulation of the genes in these two pathways after androgen and estrogen treatments suggests that they are targets of steroid hormones influencing normal phallus differentiation. The presence of conserved AR-and ER-binding sites in the promoter regions of these genes in marsupials, mice, and humans suggests that hormonal regulation is a conserved feature of these critical phallus developmental genes.
Conserved localization of SHH mRNA and β-catenin protein in the tammar phallus SHH mRNA was mainly localized in the urethral epithelium especially in fetal phalluses, similar to mice [29, 30] , rat [76] , snakes [77] , alligators [78] , and turtles [79] . At later developing stages, it was also detected in the penile shaft skin epithelium of the tammar. Since the tammar phallus differentiation occurs after birth, unlike in eutherian mammals, the epidermis of the phallus is much thicker and the epithelial cells proliferate rapidly to replace the keratin layer for protection while the young is in the pouch. This postnatal tammar phallus development may be the reason for the difference in the localization of SHH in the phallus of the tammar compared to other mammals that have only been examined at the fetal and neonatal stages. Interestingly, SHH mRNA was also found in the corpora cavernosa and in the mesenchyme around the diverticulum during its formation, indicating that SHH may be involved in several aspects of phallus development in the tammar. Although the expression of β-catenin was not overtly affected by any treatment, it is critical to maintain the integrity of epithelial cells in the phallus during its differential growth and development in males and females respectively, as in mice [42, 80] and in humans [81] . In the tammar, β-catenin was widely detected in the membranes of the epithelial cells of the phallus and the urethral epithelium, suggesting that it has the same conserved role in the tammar as in mice [42] . Interestingly, we did not see any β-catenin staining in the nucleus, suggesting that canonical pathway may not play a critical role during the stages we observed in the tammar.
The presence of androgen in the imprinting window initiated urethral closure in females but not phallus elongation Adiol treatment of females from day 20 pp to day 40 pp during the imprinting window induced complete urethral closure by day 150 pp, but the phallus length did not increase ( Figure 6 ). Unlike urethral closure, growth of the phallus appears to require extended androgen exposure [5] . Female young grafted with neonatal testes soon after birth have male-type phallus growth and urethral closure when examined at day 300 [51] and at 3 years have normal sized male phalluses [61] . In contrast, castration of males before day 25 pp results in highly feminized phalluses with an open urethra [5, 51] . Clearly, androgen is the dominant steroid controlling urethral closure and phallus elongation during tammar phallus development. Testicular androgen concentration drops by day 40-45 pp in normal males [53] , and there is no significant difference in plasma testosterone concentrations between males and females at any time up to day 70-80 pp [53, 54] , when male phalluses begin to elongate faster than female phalluses [5, 54] . However, plasma adiol is sexually dimorphic between day 20 and 40 pp, the time that prostatic development begins [56] , and is the hormone responsible for androgen imprinting at this time [5] . At the molecular level, it is possible that urethral closure and phallus elongation are controlled by two different sets of genes that have differing androgen responsiveness.
Androgen controls phallus development and regulates SHH and several WNT genes
In the tammar, SHH remains low in males before day 50 pp when testicular androgen is high, but increases transiently between day 50 and 60 pp [52] when testicular testosterone levels are low [53] , before dropping again. By removing testes or giving androgen to females, we observed an increase or decrease in SHH expression, respectively ( Figure 5 ), which further supports the suggestion that SHH is negatively regulated by androgen. Similarly, SHH expression is also decreased in human prostate cell lines after culturing with DHT, and the effect is reversed with the presence of bicalutamide, an antiandrogen [82] . PTCH2 transcripts, like the SHH transcripts, were higher in females at day 50 and increased after castration ( Figure 5 ). SHH levels increase sharply but transiently in tammar male phalluses at day 50 pp when the phallus first becomes sexually dimorphic [52] , so this may be the switch that controls the timing of phallus growth and urethral closure. In contrast, the downstream SHH genes (GLI1, GLI2, GLI3, PCTH1, and SMO) were not significantly affected by the hormonal treatments. In mice, the transcription of Ptch1 and Gli1 is only triggered after the activation of SHH signaling pathway [83, 84], so we may have missed transcriptional changes that occur after day 50 pp.
WNT5A showed a similar expression pattern to that of SHH. WNT5A was also inhibited by androgen treatment, but increased after removing the testes ( Figure 6 ). There may be an interaction between androgen, SHH, and WNT5A driving masculinization of the phallus, as occurs in knockout mice [9, 41] . WIF1 inhibits the action of WNT proteins, and in mice the expression pattern of each Wnt gene during phallus development is different [41, 45] . Therefore, it is possible that different Wnts respond to androgen differently from the hedgehog genes. Similarly in the tammar, WNT4 was upregulated by androgen treatment in females, while WNT9A was upregulated only after castration ( Figure 6 ). WNTA11 was more highly expressed in normal male phalluses than in female phalluses at day 50 pp but the expression was unaffected by androgen treatment of females or by castration in males. These results suggest that androgens control cell proliferation and survival through regulating the SHH and WNT signaling pathways during tammar phallus development as occurs in mice [9, 41] .
Estrogen inhibits phallus elongation but not androgen synthesis
Males treated with estrogen during the imprinting window had smaller penises than control males. Since constant androgen is required for maintaining phallus elongation in the tammar [5] , it is possible that estrogen treatment in males impaired normal androgen synthesis, thereby inhibiting phallus elongation. Similar results were also seen in humans [85] , rats [86] , and mice [87] . However, exposure of male tammars to estrogen between day 20 and day 40 pp did not affect the synthesis of testicular testosterone at day 50 pp nor did it alter testicular morphology. However, as well as the exogenous estrogen, these males had intact testes, so both estrogen and androgen were present in the estrogen-treated male phallus. This caused an ambiguous genitalia phenotype of a micropenis with completely closed urethra. Thus, there may be direct effects of estrogen, distinct from the effects of androgens on phallus development.
Estrogen effects on the SHH and WNT signaling pathways
Estrogen treatment in males upregulated SHH expression, but downregulated WNT7A and WIF1 expression, a pattern distinct from the effect of androgen on these genes. Estrogen had no effect on WNT4, WNT5A, or WNT9A. In human gastric cancer cells, a non-androgen producing cell line, estrogen upregulated SHH expression and induced cell proliferation in ERα-positive cells. Treatment with fulvestrant (ICI 182,780), an ERα inhibitor, prevented estrogen-induced SHH expression, suggesting that estrogen increases SHH expression through activating ERα signaling [88] . A similar pattern was also seen in human breast cancer cell lines [89] . We found ERα-binding sites near the promoter of SHH in the tammar, using the GTRD database [65] . ERα is one of the regulators of hedgehog activation in breast and gastric cancer [88, 89] . Therefore, it is likely that estrogen has a conserved and direct impact on SHH, WIF1, and WNT7A expression. These data also show that the androgen imprinting window is a period when phallus genes are not only sensitive to androgen, but also to estrogen.
Conclusions
This study confirms that androgen can induce male-pattern urethral closure in females, while estrogen can suppress phallus elongation in males, suggesting that each morphological change is sensitive to a different suite of genes. Estrogen had no effect on urethral closure when the testes remained in situ in treated males. There is clearly a robust interaction of both androgenic and estrogenic steroid hormones on genes in the SHH and WNT signaling pathways that control urethral closure and phallus growth, demonstrating that these genes are potential targets of the increasing levels of EEDs in the environment.
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